JONATHAN COPELAND: Open Payments
NPI 1730393448 · ROCHESTER HILLS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,187 in 57 payments from 17 companies in 2025. Trend: 2023 $1,681 · 2024 $1,624 · 2025 $1,187
Food & beverage: $1,187
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $298 |
| PFIZER INC. | 10 | $160 |
| ABBVIE INC. | 5 | $100 |
| Janssen Pharmaceuticals, Inc | 3 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $96 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Amgen Inc. | 3 | $37 |
| Astellas Pharma US Inc | 2 | $34 |
Products named: SPRAVATO, JARDIANCE, VRAYLAR, Ozempic, NURTEC ODT, Auvelity, AIRSUPRA, PREVNAR 20.
Industry payments across MI — which companies pay providers there.
